September 22, 2020
Healthcare delivery has certainly been affected by this Covid-19 pandemic. This is particularly true for oncology medical offices. Oncology care has been presented with several unique challenges during Covid-19, mainly related to the importance of timely care for cancer patients combined with many patients facing compromised immune function (due to either past or current cancer treatment).
Oral oncolytics have been a great option for healthcare providers to turn to, when appropriate for a patient, during this global pandemic. Intravenous medications and radiology, obviously, are not a good match for home-based care. However, oral oncolytics can be administered at home by patients. In fact, it’s been documented that there’s been in increase in oral oncolytics prescribed in 2020, since these can be a safer option for many patients.
Oral cancer therapy makes the patient-pharmacist relationship more important than ever when it comes to treatment coordination. Your medical office has a trusted partner in BioPlus Specialty Pharmacy to navigate the unique challenges of 2020.
The specialty pharmacists and other staff at BioPlus Specialty Pharmacy serve several important and unique roles for cancer patients, including treatment coordination, assistance with insurance approvals, navigation of financial assistance, management of co-morbidities and drug interactions, and the monitoring of potential adverse effects.
Remember, you can count on BioPlus in these tough times, and in the better days ahead.